dyspnea and hypoxia in COVID-19. ???? ???-???????-???????-??????? ??? ??????
Conditions
Interventions
Intervention 1: Control group: They received all the necessary medication based on the decision of the relevant medical team. Intervention 2: Intervention group: They received all the necessary medica
And also the patients were asked, after receiving adequate information and training about the procedure, to inflate a balloon, by blowing up and empty it at least 5 times a day and for a minimum 5 tim
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: = 18 years old Patients with definitive diagnosis of Covid-19 Hospitalization in non-intensive care unit dyspnea according to the patient O2-saturation <93% recorded by a pulse oximeter.
Exclusion criteria
Exclusion criteria: History of lung diseases (under treatment) History of kidney diseases (under treatment) History of heart diseases history of allergy to latex or balloon material Any case of prohibition from Intense aerobic activity by a physician the need for hospitalization in intensive care units(ICU or CCU). Pregnancy History of neurological diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of dyspnea at rest. Timepoint: At the beginning of the study (before the intervention) and on days 1 and 2 after the intervention. Method of measurement: Based on Borg Modified Scale.;Intensity of dyspnea after 50 meters of walking with pulse oximeter. Timepoint: At the beginning of the study (before the intervention) and on days 1 and 2 after the intervention. Method of measurement: Based on Borg Modified Scale.;Oxygen saturation of arterial blood without oxygen therapy. Timepoint: At the beginning of the study (before the intervention) and on days 1 and 2 after the intervention. Method of measurement: After 5 minutes of separation from the oxygen mask by the same pulse oximeter.;Arterial blood oxygen saturation with oxygen therapy. Timepoint: At the beginning of the study (before the intervention) and on days 1 and 2 after the intervention. Method of measurement: In the case of oxygen therapy, by the same pulse oximeter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Gender. Timepoint: Upon entering the study. Method of measurement: Based on identity information.;?Body mass index. Timepoint: Upon entering the study. Method of measurement: Patient weight (Kg) divided by patient height to the power of 2 (m).;Age. Timepoint: Upon entering the study. Method of measurement: Based on identity information.;Extent of pulmonary involvement. Timepoint: Upon entering the study. Method of measurement: Based on a CT scan report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Bargahi
Qazvin University of Medical Sciences
Outcome results
None listed